The Cellular and Architectural Determinants of Immune Evasion and Their Impact on Response to Therapy in Classical Hodgkin Lymphoma

IN PARTNERSHIP WITH LEUKEMIA & LYMPHOMA SOCIETY AND THE PAUL G. ALLEN FRONTIERS GROUP (2020-PRESENT)

Margaret A. Shipp, MD, Dana-Farber Cancer Institute/ Harvard Medical School